Literature DB >> 18713792

Disability and survival in Duchenne muscular dystrophy.

M Kohler1, C F Clarenbach, C Bahler, T Brack, E W Russi, K E Bloch.   

Abstract

BACKGROUND: Duchenne muscular dystrophy (DMD) leads to progressive impairment of muscle function, respiratory failure and premature death. Longitudinal data on the course of physical disability and respiratory function are sparse.
OBJECTIVES: To assess prospectively physical impairment and disability, respiratory function and survival in patients with DMD over several years to describe the course of the disease with current care.
METHODS: In 43 patients with DMD, aged 5-35 years, yearly assessments of physical disability by the Duchenne muscular dystrophy physical Impairment and Dependence on care (DID) score, ranging from 9 (no disability) to 80 (complete dependence), and forced vital capacity (FVC), were obtained over a mean time interval of 5.4 (SD 2.1) years.
RESULTS: DID scores were correlated with age according to a hyperbolic function (f = 85.3 x age/(10.05+age), R = 0.62, p<0.0001). FVC declined exponentially with age (f = 139.1 x exp(-0.08 x age), R = 0.52, p<0.0001). Mean age at which patients lost their ambulation was 9.4 (SD 2.4) years and they became dependent on an electric wheelchair at 14.6 (4.0) years. Age at the beginning of assisted ventilation was 19.8 (3.9) years, Three patients died during the observation period. The estimated probability of survival to age 30 years was 85% (median survival was 35 years).
CONCLUSIONS: Our detailed observations of the progression of physical disability, dependence on care and respiratory impairment in patients with DMD from childhood to adult life is valuable for predicting the clinical course with current medical care. Compared with historical data, survival has improved considerably.

Entities:  

Mesh:

Year:  2008        PMID: 18713792     DOI: 10.1136/jnnp.2007.141721

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  49 in total

1.  Patterns of decline in upper limb function of boys and men with DMD: an international survey.

Authors:  Mariska M H P Janssen; Arjen Bergsma; Alexander C H Geurts; Imelda J M de Groot
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

2.  TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.

Authors:  Jarrod A Call; James M Ervasti; Dawn A Lowe
Journal:  J Appl Physiol (1985)       Date:  2011-05-12

3.  Reliability, validity and description of timed performance of the Jebsen-Taylor Test in patients with muscular dystrophies.

Authors:  Mariana Cunha Artilheiro; Francis Meire Fávero; Fátima Aparecida Caromano; Acary de Souza Bulle Oliveira; Nelson Carvas; Mariana Callil Voos; Cristina Dos Santos Cardoso de Sá
Journal:  Braz J Phys Ther       Date:  2017-12-08       Impact factor: 3.377

Review 4.  Assisted standing for Duchenne muscular dystrophy.

Authors:  Katy Pedlow; Suzanne McDonough; Sheila Lennon; Claire Kerr; Ian Bradbury
Journal:  Cochrane Database Syst Rev       Date:  2019-10-13

5.  Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.

Authors:  Judith Lorant; Charlotte Saury; Cindy Schleder; Florence Robriquet; Blandine Lieubeau; Elisa Négroni; Isabelle Leroux; Lucie Chabrand; Sabrina Viau; Candice Babarit; Mireille Ledevin; Laurence Dubreil; Antoine Hamel; Armelle Magot; Chantal Thorin; Laëtitia Guevel; Bruno Delorme; Yann Péréon; Gillian Butler-Browne; Vincent Mouly; Karl Rouger
Journal:  Mol Ther       Date:  2017-10-20       Impact factor: 11.454

6.  Cardiac Phenotype-Genotype Associations in DMD/BMD: A Meta-Analysis and Systematic Review.

Authors:  Huan Zhou; Manli Fu; Bing Mao; Li Yuan
Journal:  Pediatr Cardiol       Date:  2020-10-09       Impact factor: 1.655

7.  Immunoproteasome in animal models of Duchenne muscular dystrophy.

Authors:  Chiao-Nan Joyce Chen; Ted G Graber; Wendy M Bratten; Deborah A Ferrington; LaDora V Thompson
Journal:  J Muscle Res Cell Motil       Date:  2014-06-17       Impact factor: 2.698

8.  Bone Health and Endocrine Care of Boys with Duchenne Muscular Dystrophy: Data from the MD STARnet.

Authors:  David R Weber; Shiny Thomas; Stephen W Erickson; Deborah Fox; Joyce Oleszek; Shree Pandya; Yedatore Venkatesh; Christina Westfield; Emma Ciafaloni
Journal:  J Neuromuscul Dis       Date:  2018

9.  Liberation and mortality outcomes in pediatric long-term ventilation: A qualitative systematic review.

Authors:  Candice M Foy; Monica L Koncicki; Jeffrey D Edwards
Journal:  Pediatr Pulmonol       Date:  2020-08-12

10.  Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy.

Authors:  Anne M Connolly; Elizabeth C Malkus; Jerry R Mendell; Kevin M Flanigan; J Philip Miller; Jeanine R Schierbecker; Catherine A Siener; Paul T Golumbek; Craig M Zaidman; Craig M Mcdonald; Linda Johnson; Alina Nicorici; Peter I Karachunski; John W Day; Jason M Kelecic; Linda P Lowes; Lindsay N Alfano; Basil T Darras; Peter B Kang; Janet Quigley; Amy E Pasternak; Julaine M Florence
Journal:  Muscle Nerve       Date:  2015-02-11       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.